Home
Categories
Design & Build
Patient Experience
Estates & Facilities
Technology
Mental Health
Social Care
Sustainability
Furniture & Fixtures
Digital
Infection Control
Medical Devices
Regulatory
BBH Awards
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Oxford Biosystems
Oxford Biosystems
Activities:
Analysis
Pharmaceutical
Trending Articles
NHS Trust progresses plans for new shopping centre CDC in Redhill
The new Redhill CDC build has progressed and is aiming to open in summer 2025
Yorkshire cancer diagnosis centre built without planning permission, report reveals
The £12.5 million facility near Scarborough was meant to expand diagnostic services for patients across the region, but it now faces uncertainty over its future
New report calls for urgent overhaul of hospital design to combat healthcare infections
A new cross-sector taskforce has been launched to address systemic design failings in healthcare environments and embed infection prevention measures into future hospital projects
Assura to go private in £1.6bn acquisition
KKR and Stonepeak’s cash offer has been accepted by the major healthcare estates firm, which some say will support accelerated investment in the national healthcare...
You need to be a subscriber to read this article.
Click here
to find out more.
UK spending review: Chancellor’s £29bn NHS investment puts digital transformation in the spotlight
Rachel Reeves has announced a record £29bn funding boost to get the NHS back on its feet and fit for the future, but health tech leaders warn it must be matched with long-term...
Upcoming event
The Healthcare Buildings Forum
10–11 July 2024 | Networking event | Birmingham, UK
See all